Abstract:Heart failure (HF) is a complex syndrome representing the clinical endpoint of many cardiovascular diseases of different etiology. Given its prevalence, incidence and social impact, a better understanding of HF pathophysiology is paramount to implement more effective anti-HF therapies. Based on left ventricle (LV) performance, HF is currently classified as follows: (1) with reduced ejection fraction (HFrEF); (2) with mid-range EF (HFmrEF); and (3) with preserved EF (HFpEF). A central tenet of HFrEF pathophysiology is adrenergic hyperactivity, featuring increased sympathetic nerve discharge and a progressive loss of rhythmical sympathetic oscillations. The role of reflex mechanisms in sustaining adrenergic abnormalities during HFrEF is increasingly well appreciated and delineated. However, the same cannot be said for patients affected by HFpEF or HFmrEF, whom also present with autonomic dysfunction. Neural mechanisms of cardiovascular regulation act as "controller units," detecting and adjusting for changes in arterial blood pressure, blood volume, and arterial concentrations of oxygen, carbon dioxide and pH, as well as for humoral factors eventually released after myocardial (or other tissue) ischemia. They do so on a beat-to-beat basis. The central dynamic integration of all these afferent signals ensures homeostasis, at rest and during states of physiological or pathophysiological stress. Thus, the net result of information gathered by each controller unit is transmitted by the autonomic branch using two different codes: intensity and rhythm of sympathetic discharges. The main scope of the present article is to (i) review the key neural mechanisms involved in cardiovascular regulation; (ii) discuss how their dysfunction accounts for the hyperadrenergic state present in certain forms of HF; and (iii) summarize how sympathetic efferent traffic reveal central integration among autonomic mechanisms under physiological and pathological conditions, with a special emphasis on pathophysiological characteristics of HF.

Top-notch insights into heart failure

Heart failure: advanced development in genetics and epigenetics.

Advancing heart failure management: innovations and future directions

Heart Failure and Cardiomyopathies: CT and MR from Basics to Advanced Imaging

Pharmacological and Non-Pharmacological Advancements in Heart Failure Treatment

Pathophysiological and Molecular Insights

[Advanced heart failure : what are the prospects for patients ?]

A scenario for heart failure during the filling phase

Insights into the post-translational modifications in heart failure

Pathophysiological insights into HFpEF from studies of human cardiac tissue

Gut Hormones in Heart Failure

The Gut in Heart Failure: Current Knowledge and Novel Frontiers

Advances in research on the central mechanism of heart failure

The pathophysiology of hypertensive acute heart failure

Heartfelt Breakthroughs: Elevating Quality of Life with Cutting-Edge Advances in Heart Failure Treatment

The year in cardiovascular medicine 2023: the top 10 papers in heart failure and cardiomyopathies

Heart failure - what's new and what's changed?

Cellular and molecular pathobiology of heart failure with preserved ejection fraction

Current and emerging drug targets in heart failure treatment

Contribution of Autonomic Reflexes to the Hyperadrenergic State in Heart Failure